Skip to main content

Advertisement

Table 1 List of the drugs that were most effective in inhibiting EMT in the mesenchymal MDA-MB 231 reporter cells and their reported targets

From: GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer

  Drug Target
1 TSU-68 (orantinib) VEGFR, PDGFR, FGFR
2 Rocilinostat (ACY-1215) HDAC
3 Trichostatin A (TSA) HDAC
4 CUDC-101 HDAC, HER2, EGFR
5 PD168393 EGFR
6 SCH79797 Par1 antagonist
7 CP-673451 PDGFR
8 Panobinostat (LBH589) HDAC
9 BIO GSK3
10 Cabozantinib malate VEGFR, Axl
11 GW9662 PPAR